RASopathies: Presentation at the Genome, Interactome, and Phenome Levels

Molecular Syndromology

Volumn 7, Issue 2, 2016, Pages 72-79

  Pevec, Urska ^a   Rozman, Neva ^a   Gorsek, Blaz ^a   Kunej, Tanja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Gene network; Genetic diseases; Interactome; Noonan syndrome; Phenome; RASopathies

Indexed keywords

RAS PROTEIN;

ARTICLE; COSTELLO SYNDROME; GENETIC DATABASE; GENETIC DISORDER; GENOME; GENOMICS; HUMAN; LEOPARD SYNDROME; NEUROFIBROMATOSIS TYPE 1; NOONAN SYNDROME; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN INTERACTION; RASOPATHY;

EID: 84964247900     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000445733     Document Type: Article

References (20)

1. Aoki Y, Matsubara Y: Ras/MAPK syndromes and childhood hemato-oncological diseases. Int J Hematol 97: 30-36 (2013).
2. Barabási AL: Network medicine -from obesity to the 'Diseasome'. N Engl J Med 357: 404-407 (2007).
3. Cannistraci CV, Ogorevc J, Zorc M, Ravasi T, Dovc P, Kunej T: Pivotal role of the musclecontraction pathway in cryptorchidism and evidence for genomic connections with cardiomyopathy pathways in RASopathies. BMC Med Genomics 6: 5 (2013).
4. Chen Y, Wu X, Jiang R: Integrating human omics data to prioritize candidate genes. BMC Med Genomics 6: 57 (2013).
5. Digilio MC, Lepri F, Baban A, Dentici ML, Versacci P, et al: RASopathies: clinical diagnosis in the first year of life. Mol Syndromol 1: 282-289 (2011).
6. Girirajan S, Eichler EE: Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19:R176-R187 (2010).
7. Goh K, Cusick M, Valle D, Childs B, Vidal M, Barabási AL: The human disease network. Proc Natl Acad Sci USA 104: 8685-8690 (2007).
8. Hernández-Martín A, Torrelo A: Rasopathies: developmental disorders that predispose to cancer and skin manifestations (in Spanish). Actas Dermosifiliogr 102: 402-416 (2011).
9. Kiel C, Serrano L: Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations. Mol Syst Biol 10: 727 (2014).
10. Oti M, Brunner HG: The modular nature of genetic diseases. Clin Genet 71: 1-11 (2007).
11. Oti M, Huynen MA, Brunner HG: Phenome connections. Trends Genet 24: 103-106 (2008).
12. Poot M, van der Smagt JJ, Brilstra EH, Bourgeron T: Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenet Genome Res 135: 228-240 (2011).
13. Rzhetsky A, Wajngurt D, Park N, Zheng T: Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci USA 104: 11694-11699 (2007).
14. Szklarczy D, Franceschini A, Wyder S, Forslund K, Heller D, et al: String v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43(Database issue):D447-D452 (2015).
15. Tartaglia M, Gelb BD: Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann NY Acad Sci 1214: 99-121 (2010).
16. Tartaglia M, Zampino G, Gelb BD: Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol 1: 2-26 (2010).
17. Tidyman WE, Rauen KA: The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19: 230-236 (2009).
18. van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JAM: A text-mining analysis of the human phenome. Eur J Hum Genet 14: 535-542 (2006).
19. Wu X, Jiang R, Zhang MQ, Li S: Network-based global inference of human disease genes. Mol Syst Biol 4: 189 (2008).
20. Wu X, Liu Q, Jiang R: Align human interactome with phenome to identify causative genes and networks underlying disease families. Bioinformatics 25: 98-104 (2009).